Corrigendum to "Epicutaneous immunization with protein antigen TNP-Ig and NOD2 ligand muramyl dipeptide (MDP) reverses skin-induced suppression of contact hypersensitivity" [Pharmacol. Rep. 66 (2014) 137-142]
Pharmacol Rep. 2017 Jun;69(3):587.
doi: 10.1016/j.pharep.2017.01.017.
Epub 2017 Mar 29.